DNA/GENE MICROARRAY MARKET ANALYSIS

DNA/Gene Microarray Market, By Type (Oligonucleotide DNA Microarrays, Complementary DNA Microarrays),By Application (Genomics, Proteomics, Agricultural Biology, Environment, Drug Research and Development, Cancer/oncology, Others (SNP Analysis, etc.)),By End User (Biopharmaceutical and Pharmaceutical Companies, Diagnostic Laboratories, Research Laboratories, Others (Academic Institutes, etc.)), By Geography (North America, Latin America, Europe, Middle East & Africa, and Asia Pacific)

Published In : Sep 2023
Code : CMI3825
Pages :163
Formats :
Excel and PDF
Industry : Biotechnology

Leading Companies

Global DNA/Gene Microarray Market- Cross Sectional Analysis:

The rising number of new product launches in the North America region, is expected to propel market growth over the forecast period. For instance, In April 2021, the National Center for Biotechnology Information announced the introduction of CovidArray, a microarray-based test to detect COVID-19 markers N1 and N2 in nasopharyngeal swab samples. The universal microarray can detect the genotypes of six mutated bases related to COVID-19.

Global DNA/Gene Microarray Market - Key Players

Major players operating in the global DNA/gene microarray market include Affymetrix, Inc., Illumina, Inc., Agilent Technologies Inc., Roche NimbleGen Inc., Sequenom, Inc., Biometrix Technology Inc., LC Sciences, Life Technologies Corp., Lifegen Technologies LLC, Microarrays Inc., Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., Caliper Life Sciences, Perkin Elmer, Inc., PathogenDx, Inc., Twist Bioscience Corporation, Arraylt Corporation, Molecular Device, LLC and Raybiotech Inc.